Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NICE
Pharma
Regulatory tracker: Carvykti scores EC's 2L myeloma nod
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Fraiser Kansteiner
,
Eric Sagonowsky
,
Angus Liu
,
Kevin Dunleavy
,
Zoey Becker
Apr 22, 2024 11:35am
Orchard nabs approval for first MLD gene therapy in US
Mar 18, 2024 3:25pm
NICE rejects Vertex, CRISPR's Casgevy, asks for more data
Mar 14, 2024 11:24am
NICE reverses its call on Talzenna after Pfizer discount
Jan 19, 2024 7:47am
Regulatory tracker: Merck, Biogen and more
Dec 19, 2023 8:40am
In 'historic' nod, UK signs off on Vertex, CRISPR's gene therapy
Nov 16, 2023 11:45am